It has been shown that IL-18, in synergy with IL-12, plays a key role in Th1 responses by upregulating IFN-γ, and exhibits anti-tumor activities via mediating the increase of NK cell activity and induction of tumor cell apoptosis (Srabović et al., 2011). The gene discussed is IL18; the disease is neoplasm.